Related content

Association between the cytotoxic T-lymphocyte antigen 4 +49A/G polymorphism and bladder cancer risk

By Wang Lei   Su Guixiang   Zhao Xinghua   Cai Yi   Cai Xianan   Zhang Jie   Liu Jian   Wang Tongqing   Wang Jizheng  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1139-1142

Springer Publishing Company

Access to resources Recommend Favorite

Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide–pulsed dendritic cells

By Matsuda Kenji   Tsunoda Takuya   Tanaka Hajime   Umano Yasukazu   Tanimura Hiroshi   Nukaya Ikuei   Takesako Kazutoh   Yamaue Hiroki  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 609-616

Springer Publishing Company

Access to resources Recommend Favorite

Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide

By              

International Journal of Oncology, Vol. 42, Iss. 3, 2013-01 ,pp. : 831-838

Spandidos Publications

Access to resources Recommend Favorite

Immune checkpoints: Cytotoxic T-lymphocyte antigen 4 and programmed cell death protein 1 in breast cancer surgery

By                    

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1079-1086

Spandidos Publications

Access to resources Recommend Favorite

Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian study

By Khorshied Mervat Mamdooh   Gouda Heba Mahmoud   Khorshid Ola M. Reda  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1061-1066

Informa Healthcare

Access to resources Recommend Favorite